Neuroscience luminaries clamored onto the stage at this week's World Medical Innovation Forum in Boston to present the meeting’s much-anticipated "Disruptive Dozen".
Neuroscience luminaries clamored onto the stage at yesterday’s World Medical Innovation Forum in Boston to present the meeting’s much-anticipated Disruptive Dozen. It was a truly impressive feat to pack the 14 experts onstage, let alone the difficulty of extracting real participation and interaction in the panel session.
As fellow communicators of industry and science we certainly grasp the power of an enumeration of ten (or twelve) hot button items. Although somewhat vague, as lists go, this one certainly hints at some exciting topics: #12 Diagnosing and Treating Neurodegenerative Disease Through the Microbiome, #7 New Aspects of Gene Therapy, #2 Stem Cell Therapy to Repair and Replenish the Brain, #1 Early Diagnosis and Treatment of Alzheimer’s Disease
We’ll see if the effort by Partners HealthCare physicians and researchers to manufacture clickbait can generate intrigue among experts as well as the lay public. It’s primed and packaged as fodder for Facebook and Buzzfeed, but a deeper read of the full report (available here) should inspire hope in the potential to treat diseases of mind.
Trends in Continuing Medical Education
April 12th 2024Elliott Yoo, Senior Media Strategist at epocrates, takes a closer look at the trends in CME consumption and what the future of medical education will be – from the priorities for physicians as they juggle learning with patient care, to what type of activities resonate most with prescribers.
Transforming Cancer Care: Data, AI, and Patient-Centered Care
July 20th 2023Join us as Mohit Manrao, SVP and head of US oncology at AstraZeneca, shares his patient-centered approach to transforming cancer care, bridging the gap between innovative science and tangible patient outcomes across all populations on a global scale.